EAGLE PHARMACEUTICALS, INC. Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from 2012 to 2022.
  • Eagle Pharmaceuticals, Inc. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending June 30, 2023 was $9.3M.
  • Eagle Pharmaceuticals, Inc. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending June 30, 2023 was $29.2M, a 27.7% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was $61.4M.
  • Eagle Pharmaceuticals, Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was -$4.55M, a 120% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2020 was $22.7M, a 3.09% increase from 2019.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $61.4M +$66M Jan 1, 2022 Dec 31, 2022 10-K 2023-03-23
2021 -$4.55M -$27.2M -120% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $22.7M +$679K +3.09% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $22M -$12M -35.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 $34M -$38.9M -53.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-05
2017 $72.9M +$19.5M +36.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $53.4M +$50.9M +1976% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $2.57M +$21.8M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 -$19.3M -$12.3M -177% Oct 1, 2013 Sep 30, 2014 10-K 2017-03-15
2013 -$6.95M +$13.2M +65.5% Oct 1, 2012 Sep 30, 2013 10-K 2016-02-29
2012 -$20.2M Oct 1, 2011 Sep 30, 2012 10-K 2014-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.